Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Wellbeing Digital Sciences Inc (OP: KONEF )

N/A UNCHANGED
Last Price Updated: 3:57 PM EST, Mar 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Wellbeing Digital Sciences Inc

< Previous 1 2 Next >
Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Results of UP360, a Nutraceutical Ingredient Demonstrating Beneficial Immune Defense Response
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Announces Cease Trade Order
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital to Participate at the Benzinga Psychedelic Capital Conference
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital to Participate at the Cantor Fitzgerald Virtual Panel Discussion
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital to Participate in The Global Biomedical Design Conference
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Applies for a Controlled Substances Dealers License and Receives Approval to Proceed with Buildout
From WELLBEING DIGITAL SCIENCES
Via Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital to Participate in MarigoldLIVE: International Women’s Day Networking Event
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Provides Bi-Weekly Default Status Report
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Announces Publication of Safety Studies on Paraxanthine and Comparison to Caffeine Toxicity.
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Receives Exemption Under Section 56 of the Controlled Drugs and Substances Act to Begin Psilocybin Clinical Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Announces Delay in Filing Its Financial Statements and Management Cease Trade Order
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Announces Change of Auditor
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Receives Approval for First-of-its-Kind Psylocibin Clinical Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Awarded Cannabis Research License from Health Canada
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446, a Nutraceutical Ingredient, in Positive Immune Defense Response
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary Mindscape Treats its 1,000th Patient
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Announces the Appointment of Mohammad Sharifi to Board of Directors
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Announces Resignation of Directors
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Enters into Research Contract With Nova Mentis for Phase II A Clinical Trial
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Subsidiary KGK Science Announces Successful Delivery of CBD and THC Through the Skin of Healthy Volunteers
From Wellbeing Digital Sciences Inc.
Via Business Wire
Wellbeing Digital Subsidiary KGK to Participate in Microdose Wonderland Miami Conference
From Wellbeing Digital Sciences Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.